The effects of monoclonal anti-CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia.

Charlotte K BrierleyJ StavesC RobertsH JohnsonP VyasL T GoodnoughM F Murphy

Published in: Transfusion (2019)

Treatment with Hu5F9-G4 in patients with AML resulted in an Hb decline and increased transfusion requirements. Problems with ABO blood typing and compatibility testing were widely observed and should be expected by centers treating recipients of Hu5F9-G4.

Keyphrases

acute myeloid leukemia
cardiac surgery
allogeneic hematopoietic stem cell transplantation
mental health
sickle cell disease
acute kidney injury
multiple myeloma
kidney transplantation
combination therapy
smoking cessation